1. Home
  2. DNLI vs TXNM Comparison

DNLI vs TXNM Comparison

Compare DNLI & TXNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • TXNM
  • Stock Information
  • Founded
  • DNLI 2013
  • TXNM 1917
  • Country
  • DNLI United States
  • TXNM United States
  • Employees
  • DNLI N/A
  • TXNM N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • TXNM
  • Sector
  • DNLI Health Care
  • TXNM
  • Exchange
  • DNLI Nasdaq
  • TXNM NYSE
  • Market Cap
  • DNLI 4.5B
  • TXNM 3.8B
  • IPO Year
  • DNLI 2017
  • TXNM N/A
  • Fundamental
  • Price
  • DNLI $25.05
  • TXNM $46.32
  • Analyst Decision
  • DNLI Strong Buy
  • TXNM Buy
  • Analyst Count
  • DNLI 11
  • TXNM 4
  • Target Price
  • DNLI $38.90
  • TXNM $47.75
  • AVG Volume (30 Days)
  • DNLI 788.0K
  • TXNM 842.6K
  • Earning Date
  • DNLI 11-06-2024
  • TXNM 11-01-2024
  • Dividend Yield
  • DNLI N/A
  • TXNM 3.35%
  • EPS Growth
  • DNLI N/A
  • TXNM 10.09
  • EPS
  • DNLI N/A
  • TXNM 1.97
  • Revenue
  • DNLI N/A
  • TXNM $1,906,349,000.00
  • Revenue This Year
  • DNLI N/A
  • TXNM $11.59
  • Revenue Next Year
  • DNLI $283.75
  • TXNM $4.62
  • P/E Ratio
  • DNLI N/A
  • TXNM $23.54
  • Revenue Growth
  • DNLI 204.74
  • TXNM N/A
  • 52 Week Low
  • DNLI $14.56
  • TXNM $34.63
  • 52 Week High
  • DNLI $33.33
  • TXNM $46.39
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 37.93
  • TXNM 68.35
  • Support Level
  • DNLI $26.17
  • TXNM $44.50
  • Resistance Level
  • DNLI $33.33
  • TXNM $45.20
  • Average True Range (ATR)
  • DNLI 1.64
  • TXNM 0.99
  • MACD
  • DNLI -0.13
  • TXNM 0.23
  • Stochastic Oscillator
  • DNLI 0.66
  • TXNM 98.37

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About TXNM TXNM ENERGY INC

TXNM Energy Inc is a holding company that owns regulated utility companies providing energy to houses and businesses across Texas and New Mexico using its utilities.

Share on Social Networks: